Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome

Am J Med. 1990 Mar;88(3):296-301. doi: 10.1016/0002-9343(90)90157-9.
No abstract available

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / diagnosis
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Keratitis / complications
  • Keratitis / drug therapy*
  • Labyrinth Diseases / complications
  • Labyrinth Diseases / drug therapy*
  • Male
  • Syndrome
  • Vasculitis / complications
  • Vasculitis / drug therapy*
  • Vasculitis / pathology

Substances

  • Immunosuppressive Agents